Dwarka - Delhi

Dr. Saurabh Pokhariyal

Head Of Department and Consultant - Nephrology

QUALIFICATION

PICK A TIME SLOT

₹ 1100

Dwarka - Delhi

₹ 1100-900-

You will receive an SMS with a verification code on this number.

Are you new to hospital ?

Yes No

Go back to change your appointment slot

We have sent you an OTP on

+91 8745360000

Resend OTP

Did not receive OTP? You can request for another OTP. Click on Resend OTP

Go Back

Your appointment is
confirmed.

The details will be shared via Email & SMS

Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.

Fellowship & Membership

Indian Society of Nephrology

Indian Society of Organ Transplant

The Transplantation Society

Languages Spoken

English

Hindi

Field of Expertise

Chronic Kidney Disease ( CKD )

Transplant Nephrology

Dialysis/Haemodialysis- Hemodialysis & Peritoneal Dialysis

Talks & Publications

Intradialytic Hypotension and Cardiac Arrhythmias in Patients Undergoing Maintenance Hemodialysis.Finnian R. Mc Causland, Jim A. Tumlin, Prabir Roy-Chaudhury, Bruce A. Koplan, Alexandru I. Costea, Vijay Kher, Don Williamson, Saurabh Pokhariyal, David M. Charytan : CJASN Jun 2020, 15 (6) 805-812;DOI:10.2215/CJN.06810619

Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study. Tumlin, J.A., Roy-Chaudhury, P., Koplan, B.A. Costea A, Kher V, Williamson D, Pokhariyal S, Charytan BMC Nephrol 20, 80 (2019) doi:10.1186/s12882-019-1212-6

Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Roy-Chaudhury P, Tumlin JA, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, Charytan DM; MiD investigators and committees.

Kidney Int. 2018 Apr;93(4):941-951. doi: 10.1016/j.kint.2017.11.019. Epub 2018 Feb 12

Renal transplantation across ABO barrier

P. N. Gupta • S. Pokhariyal • S. Bansal • S. Jain • V. Saxena • R. Sharma • M. Jain • P. Jha • S. K. Sethi • P. Ghosh • A. Tewari • R. Ahlawat • V. Kher

Indian Journal of Nephrology 05/2013; 23(3):214-6.

Steroid Free Transplant in a Living Donor Kidney Transplant Programme

S. B. Bansal · S. Pokhariyal · S. Jain · V. Saxena · R. Ahlawat · V. Kher · P. Ghosh Transplantation 11/2012; 94(10S):314

Antibody-Mediated Rejection in a Living Donor Kidney Transplant Programme S. B. Bansal · S. Pokhariyal · R. Sharma · P. N. Gupta · V. Kher · R. Ahlawat Transplantation 11/2012; 94(10S):1030.

Comparison of azathioprine with mycophenolate mofetil in a living donor kidney transplant programme. S. B. Bansal · V. Saxena · S. Pokhariyal · P. Gupta · V. Kher · R. Ahlawat · M. Singhal · S. Gulati.Indian Journal of Nephrology 10/2011; 21(4):258-63.

Cardiovascular evaluation in renal transplant recipients: A preliminary study. P. N. Gupta - S. Bansal ,V. Saxena ,S. Jain ,S. Pokhariyal ,R. Sharma – M. Jain – R. Goel – V. Kher Indian Journal of Transplantation>07/2011;5:3 Supplement 51

Evaluation of cardiac risk assessment in living kidney donor surgery

R. Goel ,S. Pokhariyal ,S. Jain ,S. Bansal ,V. Saxena ,R. Sharma, M. Jain, P. N. Gupta ,V. Kher Indian Journal of Transplantation>07/2011>5>3 Supplement>152

Steroid free/ Withdrawal immunosuppression in kidney transplantation a small initial experience from our centre V. Kher – S. Gulati – M. Singhal – S. Bansal – S. Pokhariyal – P. N. Gupta – V. Saxena – R. Ahlawat Indian Journal of Transplantation Volume 3, Page 32 (January–March 2009)

Impact of IL – 2R antibodies and Tac/ MMF/ Str Vs. Tac/ Aza/ Str in prevention of early rejections in a live donor kidney transplant program; Single centre experience M. Singhal – S. B. Bansal – S. Pokhariyal – S. Jain – V. Saxena – S. Gulati – V. Kher – R Ahlawat Indian Journal of Transplantation Volume 2, Pages 39-40 (July 2008)

Newer immunosuppressive drugs in organ transplantation: improving outcomes S. Pokhariyal – V. Kher Indian Journal of Transplantation

Volume 1, Pages 19-24 (October 2005)

Optimizing immunosuppressive regimes in the developing world – issues of cost vs quality. Kher V, Pokhariyal S. J Nephrology & renal transplantation 2009;2,1:136-145.

Pokhariyal S, Gulati S, Kher V – Prevention of progression of chronic kidney disease in Renal Disease – Prevention & Management – A physician prospective. Ed O P Kalra 2008; p 160-165

Pokhariyal S, Kher V,: Newer immunosuppressive drugs in organ transplantation: improving outcomes. Indian J Transplant 2005;1:19-24.

Pokhariyal S, Jain S, Kher V: Current immunosuppressive drugs in renal transplantation. Apollo Medicine 2005;Vol2, Number 3:187.

Thrombotic Thrombocytopenic Purpura, Apollo Medicine 2005;Vol2, Number 3:246-248.Jain S, Sharma R, Pokhariyal S, Kher V

Attenuating Progression of Chronic Kidney Disease (CKD) Mandal S, Jain S, Pokhariyal S, Kher V Apollo Medicine 2005;Vol2, Number 3:179-186

Duration of optimal therapy for idiopathic focal segmental glomeruloscleoris. Pokhariyal S, Gulati S, Sharma RK, Prasad N, Singh U, Gupta A, Sharma AP, Gupta RK, Mittal S, Mehta B. J Nephrol 2003; 16: 691 – 696

Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome. Gulati S, Pokhariyal S, Sharma RK, Elhence R, Kher V, Pandey CM,Gupta Nephrol Dial Transplant. 2001 Oct;16(10):2013-7.

Duration of optimal therapy for idiopathic FSGS. Prasad N, Pokhariyal S, Gulati S, Sharma RK, Gupta A, Gupta RK, Mittal S, Mehta A, Mehta B. Indian J of Nephrology, 2000; 10: 119.